Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 8.25
+0.20 (2.48%)
At close: Mar 20, 2026
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 170.36 million as of March 20, 2026. Its market cap has decreased by -76.00% in one year.
Market Cap
170.36M
Enterprise Value
496.66M
Revenue
300.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.25
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 170.36M, a decrease of -16.94%. That is a compound annual growth rate of -3.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 166.23M | -54.26% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 222.64M |
| Initiator Pharma | 210.83M |
| Xintela AB | 204.98M |
| AlzeCure Pharma AB | 204.55M |
| Isofol Medical AB | 185.53M |
| IRLAB Therapeutics AB | 135.39M |
| NextCell Pharma AB | 135.23M |
| Simris Group AB (PUBL) | 117.16M |